Prior to joining Red Arts, Chris began his career in the management consulting industry. “I am excited about this new opportunity to help deliver greater value for Red Arts’ portfolio ...

Megyn Kelly, a former Fox News host herself, quickly took to X to dispel any suggestion she was somehow back on the Fox payroll.

Cris Collinsworth is a Patrick Mahomes fan and he doesn’t care who knows it. The “Sunday Night Football” broadcaster essentially admitted as much during an interview on “Up & Adams with ...

Chris Kreider appears to be the odd forward out of the U.S. lineup and will likely serve as a healthy scratch in the first of three round robin games. “I’m ready to do whatever it takes to ...

Sale went on to make five consecutive Midsummer Classics for the White Sox from 2012-16, a streak he pushed to seven years in a row during his first two seasons with the Red Sox in 2017 and 2018.

Following his performance, Mahomes received a few "outs" from NBC analyst Cris Collinsworth, whom some fans believe gives the star quarterback preferential treatment. Asked about that treatment in ...

THE Welsh Open is closing in on a thrilling finale in Llandudno – with two crunch semi-finals TODAY! Former world champion ...

Senator Chris Murphy (D-CT) slammed the Department ... And so, yes, this is a red alert moment when this entire country has to understand that our democracy is at risk. And for what?

MAD Men star Christina Hendricks joined Irish actor Chris O'Dowd on the red carpet of his new comedy drama in Dublin tonight. The redhead was turning heads outside the IFI in a stunning black ...

The Super Bowl brings the emotions out of everyone. Kansas City Chiefs star Chris Jones dabbed his eyes with a tissue as five-time Grammy Award winner Jon Batiste sang the national anthem before ...

Defensive tackle Chris Jones is the leader of the Chiefs defense an has been a staple of the franchise since arriving in Kansas City. Now being a veteran Jones has taken up a leadership roll with ...

Curis, Inc. ("Curis") (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, yesterday presented data ...